JenaValve Technology, Inc.

JenaValve is a clinical-stage medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate about providing our physician partners with cutting edge technology aimed at improving the lives of our patients. JenaValve Technology, Inc. is headquartered in Irvine, California and we are continually expanding our footprint to meet growing patient needs across the globe.